Immupharma pulls back in an uptrend, to resume going upwards

Immupharma shares (LSE:IMM) have pulled back in the context of an uptrend, and that is supposed to be a temporary sale, giving traders and investors a good opportunity to buy long at better prices.

Price has been trending upwards since September 2017, and it moved briefly above the distribution territory at 100.00, and then pulled back below it.

Despite the pullback, price is above the EMA 56, and the Williams’ % Range period 20 is not far from the overbought territory.

Immupharma is expected to continue going upwards from here, going above the distribution territory at 100.00 and then going towards other distribution territories at 101.00 and 102.00.

Azeez Mustapha

Market Analyst, Trading Signals Provider and Coach

Traders’ Mindset: http://www.advfnbooks.com/books/insights/index.html 

  

Source: http://uk.advfn.com/newspaper/authors/azeez-mustapha

Buy and sell Perfect Money/Payeer/Epay; get funded quickly: www.ituglobalfx.com.ng

Start your journey to permanent success: http://www.tallinex.com/open-account?i=128521